Psychosocial challenges associated with perinatally acquired HIV (PHIV) infection are well known, yet many children infected with HIV since birth demonstrate positive outcomes, referred to as resilience. The purpose of this study was to evaluate emotional–behavioral development and identify salient predictors of resilience among long-term survivors of PHIV.
Prospective investigation of children with PHIV compared with demographically similar perinatally HIV-exposed but uninfected (PHEU) and HIV-unexposed, uninfected (HUU) children, all from Thailand and Cambodia.
The Child Behavior Checklist (CBCL; parent version) was administered at baseline and annual follow-up visits (median follow-up of 3 years) to children age 6–14. Resilience was defined as consistent CBCL scores on the Internalizing, Externalizing or Total Problem T scales within normative ranges (T-scores <60) at every time point. Generalized estimating equations examined CBCL scores over time and logistic models examined demographic, socioeconomic, and cultural predictors of resilience.
Participants included 448 children (236 PHIV, 98 PHEU, 114 HUU), with median (interquartile range) age at first evaluation of 7 (6–9) years. Children with PHIV exhibited similar rates of resilience as PHEU and HUU on the Externalizing and Total Problems scales. Resilience on the Internalizing scale was more likely in PHEU (71%) compared with PHIV (59%) or HUU (56%), P = 0.049. Factors associated with resilience in adjusted models included: HIV-exposed but uninfected status, higher household income, Cambodian nationality, female sex, and caregiver type.
Despite biopsychosocial risks, resilience is observed among PHIV and PHEU children. Further study is needed to understand mechanisms underlying associated factors and intervention priorities.
aDepartment of Psychiatry and Behavioral Science, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
bHIV-NAT, The Thai Red Cross AIDS Research Center, Bangkok, Thailand
cMissouri Institute of Mental Health, University of Missouri-St. Louis, St. Louis, Missouri, USA
dDepartment of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok
eDepartment of Psychology, Faculty of Humanities, Chiang Mai University, Chiang Mai
fDepartment of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen
gDepartment of Pediatrics, Chiangrai Prachanukroh Hospital, Chiang Rai
iResearch Institute for Health Sciences, Chiang Mai
jPrapokklao Hospital, Chanthaburi
kQueen Savang Vadhana Memorial Hospital, Chonburi
lBamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand
mUniversity of Health Science
nNational Center for HIV/AIDS Dermatology and STDs, Phnom Penh, Cambodia
oTREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand
pDepartment of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, California, USA
qSEARCH, Thai Red Cross AIDS Research Centre, Bangkok, Thailand
rThe Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda
sU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA
tDepartment of Global Health, University of Amsterdam, Amsterdam, The Netherlands
uHIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, Columbia University, New York, New York, USA.
Correspondence to Kathleen M. Malee, PhD, Ann & Robert H. Lurie Children's Hospital, 225 E. Chicago Avenue, Box 155, Chicago, IL 60611, USA. Tel: +1 312 227 8271; e-mail: email@example.com
Received 23 March, 2018
Revised 6 February, 2019
Accepted 7 February, 2019
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.AIDSonline.com).